Human Infection with Avian Influenza A Virus: Information for Health Professionals and Laboratorians
![doctor-hallway-banner-1200px doctor standing in hallway with arms crossed](./healthprofessionals_htm_files/doctor-hallway-banner-1200px.jpg)
Prevention, Monitoring, Public Health Investigations
Testing and Reporting
Enhanced Surveillance
Antiviral Treatment and Chemoprophylaxis
Evaluating and Managing Patients
Treatment
Chemoprophylaxis of Persons with Bird Exposure
Chemoprophylaxis of Close Contacts
Case Definitions
HAN: CDC Health Advisories
- Highly Pathogenic Avian Influenza A(H5N1) Virus: Identification of Human Infection and Recommendations for Investigations and Response: April 5, 2024
- Highly Pathogenic Avian Influenza A(H5N1) Virus: Recommendations for Human Health Investigations and Response April 29, 2022
- Bird Infections with Highly-Pathogenic Avian Influenza A (H5N2), (H5N8), and (H5N1) Viruses: Recommendations for Human Health Investigations and Response (Archived) June 2, 2015
Vaccine Development
- Candidate vaccine viruses and potency testing reagents for influenza A(H5N1), WHO [271 KB, 3 pages]
- Making a Candidate Vaccine Virus (CVV) for a Highly Pathogenic Avian Influenza (Bird Flu) Virus
- Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses, WHO [198 KB, 3 pages]
- Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza vaccines against avian influenza A(H7N9) virus